Form 4 Tracker
Eton Pharmaceuticals, Inc.
ETON

24 insider filings · Latest: Oct 6, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Oct 6, 2026Oct 6 8:49 PMDavid KrempaChief Business Officer
Sale
4,166$55.07$229.4K43,381(D)

View →

Oct 6, 2026Oct 6 8:05 PMKrempa David
Proposed Sale
4,166$55.07$229.4K—

View →

Aug 28, 2026Aug 31 8:06 PMPaul V MaierDirector
Sale
50,000$59.07$3.0M59,745(D)

View →

Aug 28, 2026Aug 28 8:51 PMPaul V MaierDirector
Sale
50,000$59.07$3.0M59,745(D)

View →

Aug 28, 2026Aug 28 8:41 PMMAIER PAUL V
Proposed Sale
50,000$59.07$3.0M—

View →

Aug 24, 2026Aug 24 9:19 PMDavid KrempaChief Business Officer
Sale
25,000$65.07$1.6M37,025(D)

View →

Aug 24, 2026Aug 24 8:19 PMKrempa David
Proposed Sale
25,000$65.07$1.6M—

View →

Aug 20, 2026Aug 20 10:26 PMBRYNJELSEN SEANDirector, President & CEO
Sale
91,022$60.70$5.5M961,194(D)

View →

Aug 19, 2026Aug 20 10:26 PMBRYNJELSEN SEANDirector, President & CEO
Sale
8,978$62.65$562.5K1,052,216(D)

View →

Aug 19, 2026Aug 20 9:01 PMBRYNJELSEN SEAN
Proposed Sale
100,000$63.43$6.3M—

View →

Aug 19, 2026Aug 19 2:49 PMBRYNJELSEN SEAN
Proposed Sale
100,000$63.43$6.3M—

View →

Jul 14, 2026Jul 17 11:12 PMOpaleye Management Inc.10% Owner
Sale
28,315$37.54$1.1M40,000(I)

View →

Jul 14, 2026Jul 16 9:14 PMOpaleye Management Inc.10% Owner
Sale
28,315$37.54$1.1M40,000(I)

View →

Jul 7, 2026Jul 7 10:29 PMOpaleye Management Inc.10% Owner
Sale
26,685$38.37$1.0M53,315(I)

View →

Jul 6, 2026Jul 7 10:29 PMOpaleye Management Inc.10% Owner
Sale
10,000$38.00$380.0K2,700,000(I)

View →

Jul 2, 2026Jul 7 10:29 PMOpaleye Management Inc.10% Owner
Sale
90,000$37.39$3.4M60,000(I)

View →

Jun 26, 2026Jun 26 8:14 PMGruber James R.
Proposed Sale
251,818$35.70$9.0M—

View →

Jun 25, 2026Jun 25 8:12 PMGruber James R.
Proposed Sale
25,000$35.01$875.3K—

View →

Jun 23, 2026Jun 23 8:32 PMGruber James R.
Proposed Sale
25,000$33.23$830.9K—

View →

Jun 17, 2026Jun 17 9:08 PMJennifer Mckie AdamsDirector
Sale
50,000$32.48$1.6M0(D)

View →

Page 1 of 2

Next →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
May 22, 2026May 27 10:28 PMDavid KrempaChief Business Officer
Option Exercise
30,591$3.58125,609(D)

View →

Apr 21, 2026Apr 22 8:40 PMNorbert G RiedelDirector
Option Exercise
32,155$8.610(D)

View →

Feb 3, 2026Feb 5 10:18 PMNorbert G RiedelDirector
X
30,000$4.420(D)

View →

← Previous

Page 2 of 2